Theodoros Tselios

Title: Theodoros Tselios: Innovator in Immunology

Introduction

Theodoros Tselios is a notable inventor based in Messolonghi, Greece. He has made significant contributions to the field of immunology through his innovative research and patenting efforts. His work focuses on developing novel therapeutic approaches for treating immune disorders.

Latest Patents

Theodoros Tselios holds a patent for "Conjugates comprising mannan and myelin oligodentrocyte glycoprotein (MOG)." This invention includes a conjugate that features mannan linked to at least one epitope comprising a peptide fragment of proteins such as myelin basic protein (MBP), myelin oligodentrocyte glycoprotein (MOG), and proteolipid protein (PLP). The peptide fragment can be in either linear or cyclic form, and it is linked to mannan via a [(Lys-Gly)] bridge, where n is an integer from 1 to 10. The patent also covers pharmaceutical compositions that utilize these conjugates for the preparation of medicaments aimed at treating immune disorders.

Career Highlights

Theodoros Tselios is associated with Vianex S.A., a company known for its commitment to pharmaceutical innovation. His work at Vianex has allowed him to explore and develop groundbreaking solutions in the medical field, particularly in immunology.

Collaborations

Throughout his career, Theodoros has collaborated with esteemed colleagues such as Vasso Apostolopoulos and Vivian Tseveleki. These collaborations have further enriched his research and contributed to advancements in the field.

Conclusion

Theodoros Tselios is a prominent figure in the realm of immunology, with a focus on innovative therapeutic solutions. His patent for conjugates involving mannan and MOG exemplifies his commitment to addressing immune disorders. His contributions continue to pave the way for future advancements in medical science.